mtm laboratories announced the publication of a new paper showing that dual staining for p16 and Ki-67 can pinpoint the underlying high-grade cervical disease with a high degree of sensitivity and specificity in women with ASC-US or LSIL cytology results. These are a group of patients curre ... more
mtm laboratories opens subsidiaries in Italy, France and Spain to support the commercialization of its diagnostic products
01-11-2007: mtm laboratories announced the opening of new subsidiaries by the Company in Italy (Milan), France (Paris) and Spain (Madrid) in order to commercialize its CE-labeled diagnostic products in Europe. When combined with Germany, these additional European markets represent approximately 65% of the total European cervical cancer screening market. Through these new subsidiaries, mtm plans to commercialize its proprietary p16INK4a based products in major European markets starting in January 2007.
-
News
p16 Immuno-cytochemistry shows superior clinical performance to HPV testing
mtm laboratories announced the publication of a large study in the American Journal of Clinical Pathology that evaluated the clinical performance of the CE-labeled CINtec® Cytology kit in managing equivocal or mildly abnormal cytologic results. The publication authored by Denton and collea ... more
mtm laboratories announced the opening of new subsidiaries by the Company in Italy (Milan), France (Paris) and Spain (Madrid) in order to commercialize its CE-labeled diagnostic products in Europe. When combined with Germany, these additional European markets represent approximately 65% of ... more
- 1Schleicher & Schuell has been purchased by Whatman plc
- 2SCHOTT Instruments has changed its name to SI Analytics
- 3VWR International, LLC Signs Agreement to Acquire basan Germany GmbH
- 4SGS Minerals Services opens new lab in Chennai, India
- 5MDS Sciex Opens Manufacturing Facility in Singapore
- 6Sartorius opens new plant in India
- 7Affymetrix and eBioscience Amend Definitive Merger Agreement
- 8Fluidigm China Opens Its Doors
- 9Thermo Fisher Scientific Acquires NanoDrop Technologies
- 10PIAB announces new Chief Executive Officer
- QIAGEN and Pathway Diagnostics Sign Agreement to Address Biomarker Development Needs in Pharma -
- Galapagos expands and extends drug discovery collaboration with Amgen into 2008 -
- New technology makes clinical research more precise -
- Eight of the total of 16 Reference Laboratories within BfR have been newly appointed -
- Orion Genomics Announces Notice Of Allowance For US Patent Covering Genome Wide Novel Biomarker Discovery Platform -





